Language selection

Search

Patent 2481603 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent Application: (11) CA 2481603
(54) English Title: METHOD AND COMPOSITION FOR IMPROVING FERTILITY HEALTH IN FEMALE AND MALE ANIMALS AND HUMANS
(54) French Title: PROCEDE ET COMPOSITION D'AMELIORATION DE LA FERTILITE CHEZ DES HUMAINS ET DES ANIMAUX MALES ET FEMELLES
Status: Dead
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 33/30 (2006.01)
  • A61K 31/122 (2006.01)
  • A61K 31/197 (2006.01)
  • A61K 31/198 (2006.01)
  • A61K 31/205 (2006.01)
  • A61K 31/30 (2006.01)
  • A61K 31/355 (2006.01)
  • A61K 31/375 (2006.01)
  • A61K 31/409 (2006.01)
  • A61K 31/4415 (2006.01)
  • A61K 31/519 (2006.01)
  • A61K 31/525 (2006.01)
  • A61K 31/714 (2006.01)
  • A61K 33/04 (2006.01)
  • A61K 33/06 (2006.01)
  • A61K 33/26 (2006.01)
  • A61K 36/232 (2006.01)
  • A61K 36/73 (2006.01)
  • A61K 36/82 (2006.01)
  • A61K 36/85 (2006.01)
  • A61P 15/08 (2006.01)
  • A01N 65/00 (2006.01)
(72) Inventors :
  • TRANT, AILEEN SONTAG (United States of America)
(73) Owners :
  • THE DAILY WELLNESS COMPANY (United States of America)
(71) Applicants :
  • THE DAILY WELLNESS COMPANY (United States of America)
(74) Agent: R. WILLIAM WRAY & ASSOCIATES
(74) Associate agent:
(45) Issued:
(86) PCT Filing Date: 2002-04-08
(87) Open to Public Inspection: 2003-10-23
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US2002/010854
(87) International Publication Number: WO2003/086080
(85) National Entry: 2004-10-08

(30) Application Priority Data: None

Abstracts

English Abstract




In a new supplemental combination, the herb, Vitex agnus-castus (chasteberry),
enhances hormone balance by increasing luteinizing hormone (LH) and
progesterone release and, therefore, ovulation frequency. The antioxidants,
green tea, vitamin E, and selenium, improve overall reproductive health. L-
arginine, an amino acid, stimulates the reproductive organs by improving
circulation. Folic acid, vitamins B6 and B12, iron, zinc and magnesium help
promote women's fertility. For men, a combination of L-carnitine,
antioxidants, folic acid, zinc and B vitamins can improve fertility. L-
carnitine, an amino acid improves sperm quality and motility. Ferulic acid, an
antioxidant found in Dong quai, also improves sperm quality. Sperms are highly
susceptible to free radical or oxidative damage from environmental toxicants
and natural aging. Vitamins C and E, green tea, and selenium are all potent
antioxidants that help improve overall reproductive health. zinc and B
vitamins (B6, B 12 and folate) are critical nutrients in male reproductive
systems for hormone metabolism sperm formation and motility.


French Abstract

Selon cette invention, dans un nouveau mélange complémentaire, l'herbe, Vitex agnus-castus (chasteberry), améliore l'équilibre hormonal par accroissement de l'hormone lutéinisante (LH) et la libération de progestérones, et donc la fréquence d'ovulation. Les antioxydants, le thé vert, la vitamine E et le sélénium améliorent l'ensemble de la santé de la reproduction. L-arginine, un acide aminé, stimule les organes reproducteurs par amélioration de la circulation. L'acide folique, les vitamines B6 et B12, le fer, le zinc et le magnésium favorisent la fertilité chez la femme. Un mélange de L-carnitine, d'antioxydants, d'acide folique, de zinc et de vitamines B permet d'augmenter la fertilité chez les hommes. L-carnitine, un acide aminé, améliore la motilité et la qualité du sperme. L'acide férulique, un antioxydant découvert dans le dong quai, permet également d'accroître la qualité du sperme. Les spermes sont très sensibles aux dommages d'oxydants et de radicaux libres provenant de substances toxiques environnementales et du vieillissement naturel. Les vitamines C et E, le thé vert, et le sélénium représentent tous des antioxydants puissants qui favorisent l'ensemble de la santé reproductive. Le zinc et les vitamines B (B6, B 12 et folate) constituent des nutriants essentiels pour les appareils reproductifs mâles, en matière de motilité et de formation du sperme du métabolisme hormonal.

Claims

Note: Claims are shown in the official language in which they were submitted.




7


I claim:

1. A pharmaceutical composition having fertility
promoting activity in females comprising in combination
components in effective amounts of Vitex agnus-castus
(chasteberry), antioxidants, including green tea, vitamin E
or selenium, L-arginine, folic acid, vitamins B6 and B12,
iron, zinc and magnesium.

2. The pharmaceutical composition of claim 1, wherein
the components are present in the proportion in parts by
weight of:
about 2 to 20% Vitex agnus-castus (chasteberry),
about 5 to 50% antioxidants, including green tea,
vitamin E or selenium,
about 10 to 80% L-arginine, an amino acid,
about .001 to 1% folic acid,
about .001 to 1% vitamins B6 and B12,
about .1 to 10% iron,
about .1 to 10% zinc, and
about 5 to 50% magnesium.

3. The pharmaceutical composition of claim 1, wherein
the components are present in the proportion in parts by
weight of
about 4 to 20% Vitex agnus-castus (chasteberry),
about 20 to 50% antioxidants, including green tea,
vitamin E or selenium,
about 40 to 80% L-arginine, an amino acid,
about .01 to 1% folic acid,


8


about .3 to 1% vitamins B6 and B12,
about .1 to 5% iron,
about .1 to 5% zinc, and
about 20 to 50% magnesium.

4. A pharmaceutical composition having. fertility
promoting activity in females comprising in combination
components in effective amounts of the following components
present in proportions in parts by weight of
about 1 to 20% Vitex agnus-castus (chasteberry),
about 5 to 50% antioxidants, including green tea,
vitamin E or selenium,
about 10 to 80% L-arginine, an amino acid,
about .01 to 1% folic acid,
about .01 to 1% vitamins B6 and B12,
about .1 to 10% iron,
about .1 to 10% zinc, and
about 20 to 50% magnesium.

5. A pharmaceutical composition having fertility
promoting activity in males comprising in combination
components in effective amounts vitamins C and E, selenium,
ferulic acid, zinc and B vitamins.

6. The pharmaceutical composition of claim 5, further
comprising in combination with the other components an
effective amount of L-carnitine.

7. The pharmaceutical composition of claim 6, wherein
the components are present in the proportion in parts by
weight of


9


about 20 to 80% L-carnitine,
about 5 to 30% vitamins C and E,
about 0 to 10% coenzyme Q10,
about .001 1% to selenium,
about .2 to 20% ferulic acid,
about .1 to 2% zinc, and
about .001 to 1% B vitamins.

8. The pharmaceutical composition of claim 5, wherein
the components are present in the proportion in parts by
weight of
about 10 to 80% L-carnitine,
about 5 to 50% vitamins C and E,
about 0 to 15% coenzyme Q10,
about .001 to 1% selenium,
about .2 to 20% ferulic acid,
about .1 to 15% zinc, and
about .001 to 1% B vitamins.

9. The pharmaceutical composition of claim 5, wherein
the components are present in the proportion in parts by
weight of
about 60% L-carnitine,
about 25% vitamins C and E,
about 8% Dong Quai containing ferulic acid,
about 5% zinc and B vitamins,
about 2% coenzyme coQ10, and
about .6% selenium.

10. A supplement, comprising a herb, Vitex agnus-castus


10


(chasteberry) for enhancing hormone balance, increasing
progesterone release and ovulation frequency, antioxidants,
green tea, vitamin E, and selenium for improving reproductive
fertility, L-arginine, an amino acid for stimulating
reproductive organs by improving circulation, folic acid,
vitamins B6 and B12, iron, zinc and magnesium for promoting
women's fertility.

11. A method of promoting fertility health in women
comprising taking a dietary supplement of L-arginine,
magnesium, green tea, vitamin E, Vitex agnus-castus, iron,
zinc, selenium, vitamins B6 and B12 and folic acid.

12. The method of claim 11, wherein the dietary
supplement further comprises the following components in
percentages by weight: about 50o L-arginine, about 200
magnesium, about 10% green tea, about 10% vitamin E, about 5%
Vitex, about 1% iron, about to zinc and less than about to of
each selenium, vitamins B6 and B12 and folic acid.

13. The method of claim 11, wherein the components are
present in the proportion in parts by weight of about 10 to
80o L-arginine, an amino acid, about 5 to 50% magnesium,
about 5 to 50% antioxidants, including green tea, vitamin E
or selenium, 2 to 20% Vitex agnus-castus (chasteberry), about
.1 to 10% iron, about .1 to 10% zinc, about .001 to 1% folic
acid, about .001 to 1% vitamins B6 and B12.

14. The method of claim 11, wherein the components are
present in the proportion in parts by weight of about 40 to
80% L-arginine, an amino acid, about 20 to 50% antioxidants,


11


including green tea, vitamin E or selenium, about 20 to 50%
magnesium, about 4 to 20% Vitex agnus-castes (chasteberry),
about 1 to 10% iron, about 1 to loo zinc, about .01 to to
folic acid, and about .3 to 1% vitamins B6 and B12.

15. A method for promoting fertility health in women
comprising taking a supplement having fertility promoting
activity in females comprising in combination components in
effective amounts of the following components present in
proportions in parts by weights of about 10 to 80% L-
arginine, an amino acid, about 10 to 50% magnesium, about 5
to 50% antioxidants, including green tea, vitamin E or
selenium, about 1 to 20% Vitex agnus-castes (chasteberry),
about .1 to 10% iron, about .1 to 10% zinc, about .01 to 1%
folic acid, and about .01 to 10% vitamins B6 and B12.

16. A supplement having fertility promoting activity in
females comprising in combination components in effective
amounts of Vitex agnus-castes (chasteberry), antioxidants,
including green tea, vitamin E or selenium, L-arginine, folic
acid, vitamins B6 and B12, iron, zinc and magnesium as a
treatment for promoting fertility activity in females.

17. The method of claim 16, wherein the components are
present in the proportion in parts by weight of about 10 to
80% L-arginine, an amino acid, about 5 to 50% magnesium,
about 5 to 50% antioxidants, including green tea, vitamin E
or selenium, 2 to 50% Vitex agnus-castes (chasteberry), about
.1 to 10% iron, about .1 to 10% zinc, about .001 to 1% folic
acid, about .001 to 1% vitamins B6 and B12.


12


18. The method of claim 16, wherein the components are
present in the proportion in parts by weight of about 40 to
80% L-arginine, an amino acid, about 20 to 50% antioxidants,
including green tea, vitamin E or selenium, about 20 to 500
magnesium, about 4 to 20% Vitex agnus-castus (chasteberry),
about .1 to 5% iron, about .1 to 5% zinc, about .01 to 1%
folic acid, and about .3 to 1% vitamins B6 and B12.

19. The method of claim 16, further comprising a
supplement having fertility promoting activity in females
comprising in combination components in effective amounts of
the following components present in proportions in parts by
weights of about 10 to 80% L-arginine, an amino acid, about
to 50% magnesium, about 5 to 50% antioxidants, including
green tea, vitamin E or selenium, about 1 to 20% Vitex agnus-
castus (chasteberry), about .1 to 10% iron.

20. A method of promoting a women's fertility by taking
a new supplement, comprising a herb, Vitex agnus-castus
(chasteberry) for enhancing hormone balance, increasing
progesterone release and ovulation frequency, antioxidants,
green tea, vitamin E, and selenium for improving overall
reproductive health, L-arginine, an amino acid for
stimulating reproductive organs by improving circulation,
folic acid, vitamins B6 and B12, iron, zinc and magnesium for
promoting women's' fertility.

21. A pharmaceutical composition having fertility
promoting activity in males, comprising in combination
components in effective amounts of antioxidants, including


13


green tea, vitamin C, vitamin E or selenium, L-carnitine,
ferulic acid in Dong quaff, vitamins B6, B12, folate and zinc.

22. The pharmaceutical composition of claim 21, wherein
the components are present in the proportion in parts by
weight of:
about 5 to 50% antioxidants, including green tea,
vitamin C, vitamin E or selenium,
about 10 to 80% L-carnitine, an amino acid,
about 0 to 1% ferulic acid in Dong quaff,
about 0 to 1% vitamins B6, B 12 and folate
about 0 to 10% zinc.

23. The pharmaceutical composition of claim 21, wherein
the components are present in the proportion in parts by
weight of

about 20 to 50% antioxidants, including green tea,
vitamin C, vitamin E or selenium,
about 40 to 80% L-carnitine, an amino acid,
about 0.01 to 1% ferulic acid in Dong quai,
about 0.003 to 1% vitamins B6 and B12, and folate
about 1 to 10% zinc.

24. A pharmaceutical composition having fertility
promoting activity in males comprising in combination
components in effective amounts of the following components
present in proportions in parts by weight of:
about 5 to 50% antioxidants, including green tea,
vitamin C, vitamin E or selenium,
about 10 to 80% L-carnitine, an amino acid,



14


about 0.01 to 1% ferulic acid in Dong quai,
about 0.01 to 1% vitamins B6, B12 and folate,
about 0.1 to 10% zinc.

25. A pharmaceutical composition having fertility
promoting activity in males comprising in combination
components in effective amounts vitamins C and E, selenium,
ferulic acid, zinc and B vitamins.

26. The pharmaceutical composition of claim 25, further
comprising in combination with the other components an
effective amount of L-carnitine fumarate.

27. A pharmaceutical composition of claim 26, wherein
the components are present in the proportion in parts by
weight of
about 20 to 80% L-carnitine fumarate,
about 5 to 30% vitamins C and E,
about 1 to 30% green tea,
about 0.001 to 1% selenium,
about 2 to 20% Dong quai,
about 0.1 to 2% zinc, and
about 0.001 to 1% B Vitamins.

28. A pharmaceutical composition of claim 26, wherein
the components are present in the proportion in parts by
weight of
about 20 to 80% L-carnitine fumarate,
about 5 to 30% vitamins C and E,
about 0.1 to 30% green tea,
about 0.001 to 1% selenium,


15


about 2 to 20% Dong quai,
about .1 to 2% zinc, and
about 0.001 to 1% B Vitamins.

29. A pharmaceutical composition of claim 25, wherein
the components are present in the proportion in parts by
weight of
about 10 to 80% L-carnitine
about 5 to 50% vitamins C and E,
about 1 to 30% green tea,
about 0.001 to 1% selenium,
about 0.2 to 20% Dong quai,
about 0.1 to 5% zinc, and
about 0.001 to 1% B vitamins.

30. A pharmaceutical composition of claim 25, wherein
the components are present in the proportion in parts by
weight of
about 50% L-carnitine,
about 23% vitamins C and E,
about 8% Dong quai,
about 2% zinc and B vitamins, and
about 17% green tea.

31. A new supplement for enhancing male fertility
health, comprising antioxidants, green tea, vitamin C,
vitamin E, and selenium for improving overall reproductive
health, L-carnitine, an amino acid, vitamins B6 and B12 and
zinc for promoting men's fertility.

32. A method of promoting fertility health in men


16


comprising taking a dietary supplement of L-carnitine, Dong
quai, green tea, vitamins B6, B12, C, E, folate, zinc and
selenium.

33. A method of claim 32, wherein the dietary
supplement further comprises the following components in
percentages by weight: about 50% L-carnitine, about 17% green
tea, about 8% Dong quai, about 23% vitamins C and E, about 1%
zinc and less than about 1% of each selenium, vitamins B6 and
B12 and folate.

34. A method of promoting fertility health in men
comprising taking a supplement having fertility promoting
activity in males comprising in combination components in
effective amounts of the following components present in
proportions in parts by weights of about 10 to 80% L-
carnitine, an amino acid, about 5 to 50% antioxidants,
including green tea, vitamin C, vitamin E or selenium, about
.1 to 10% zinc, about .01 to 1% ferulic acid, and about .01
to 10% vitamins B6, B12 and folate.

35. A supplement having fertility promoting activity in
males comprising in combination components in effective
amounts of antioxidants, including green tea, vitamin C, E or
selenium, L-carnitine, Dong quai, vitamins B6, B12, folate
and zinc adapted for use as a treatment for promoting
fertility in males.

36. A method of promoting men's fertility by taking a
new supplement, comprising antioxidants, green tea, vitamin
C, vitamin E, and selenium for improving overall reproductive


17


health, L-carnitine, an amino acid for improving sperm
quality, ferulic acid in Dong quaff, vitamins B6, B12, folate
and zinc for promoting men's fertility.

Description

Note: Descriptions are shown in the official language in which they were submitted.




CA 02481603 2004-10-08
WO 03/086080 - PCT/US02/10854
1
Method and Composition for Improving Fertility Health in
Female and Male Animals and Humans
BACKGROUND OF THE INVENTION
Because of delayed child bearing, unhealthy diets and
use of tobacco, caffeine, alcohol, drugs and environmental
contaminants, difficulties in conceiving have been
experienced.
Needs exist for pharmaceutical compounds that improve
fertility in both women and men.
SUMMARY OF THE INVENTION
This invention provides combinations of bioeffecting
compounds for promoting fertility in men and women. The
combinations include nutritional components that benefit
fertility health. All the components have been studied
separately, to determine their individual efficacy. The
invention provides the first products to put these components
together synergistically in women's and men's formulations.
As many as 15% of couples in the U.S. have difficulty
conceiving a child. In about one third of these cases, it is
the man that is infertile; in another third, the female has
fertility issues. The remaining is due to a combination of
male and female fertility issues, or unknown causes. In many
of these cases, causes of infertility are treatable.
Nutritional and lifestyle changes should be the first step to
increasing chances for conception. Smoking and caffeine,
drug and alcohol consumption, environmental toxicants, and
stress are related to infertility in men and women.
Reproductive organs are highly susceptible to free radical or
oxidative damage from environmental toxicants. and natural
aging. A balanced, nutritional diet, and nutritional
supplements with high antioxidant content can help reverse
some of that damage. Other nutrients such as L-carnitine, B
vitamins and zinc are critical to sperm formation and
metabolism. In women, hormone balance is critical to monthly
ovulation and development of the corpus luteum (an ovarian



CA 02481603 2004-10-08
WO 03/086080 PCT/US02/10854
2
follicle that release progesterone after release of the egg
to prepare the uterus for implantation).
These and further and other objects and features of the
invention are apparent in the disclosure, which includes the
above ongoing written specification with the claims.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
The invention provides combinations of beneficial
bioeffecting compounds for promoting fertility in women. The
invention provides a scientifically validated
herbal/nutritional blend for women to improve infertility by
helping to regulate the menstrual cycle and correct hormone
imbalance (corpus luteum insufficiency) without increased
chances of multiple births associated with drug therapy.
The combination of amino acids, herbs, vitamins and minerals
improves overall health and helps with many of the
deficiencies that decrease fertility.
The herb, Vitex agnus-castus (chasteberry), enhances
hormone balance in women by increasing luteinizing hormone
and progesterone release and, therefore, ovulation frequency.
The antioxidants, green tea, vitamin E, and selenium, improve
overall reproductive health. L-arginine, an amino acid,
stimulates the reproductive organs by improving circulation.
Folic acid, vitamins B6 and B12, iron, zinc and magnesium
help promote womens' fertility.
The invention provides combinations of beneficial
bioeffecting compounds for promoting fertility in men. Sperm
are highly susceptible to free radical or oxidative damage
from environmental toxicants and natural aging. Vitamins C
and E, green tea, with or without coenzyme Q10, and selenium
are all potent antioxidants that help improve sperm count and
quality. Ferulic acid, an antioxidant~found in Dong Quai,
also improves sperm quality. Zinc and B vitamins (B6, B12
and folate) are critical nutrients in male reproductive
systems for hormone metabolism, sperm formation and motility.
The amino acid, L-carnitine, promotes formation of healthy



CA 02481603 2004-10-08
WO 03/086080 PCT/US02/10854
3
sperm. L-carnitine fumarate is preferred. L-carnitine
tartrate may be used.
The invention provides synergistic action of the
combinations.
The two dietary supplements in male and female formulas
are useful for men and women. Preferably, the distinct
combinations are taken by both members of a couple in which
the female age is between 21 and 46. The distinct
combinations are useful for couples who have tried for 6
months or more, up to three years, to become pregnant without
success. Preferably, patients take 2-4 capsules per day of
the distinct formulas for three months.
Preferred ranges of the combinations considered in
percent by weight are:
Women's Formula
Components Minimum % Maximum
Vitex
(chasteberry) 2 10


L-arginine 40 60


Green tea 5 20


Vitamin E 5 20


Selenium .O1 1


Vitamins


B6, B16 .O1 1


Folic acid .O1 1


Iron .1 5


Magnesium 10 40


Zinc .1 5


Men's Formula
Components Minimum % Maximum
L-carnitine 40 70


Ferulic acid
in


Dong Quai .O1 10


Vitamins


C and E 10 40


Coenzyme


coQlO 0 5


Selenium .O1 1


Zinc .1 10


B vitamins .001 1





CA 02481603 2004-10-08
WO 03/086080 PCT/US02/10854
4
Acceptable ranges of womens' and mens' formulations are:
Women's Formula
Components Minimum % Maximum
Vitex
(chasteberry) 1 20


L-arginine 20 70


Green tea 0 30


Vitamin E .O1 30


Selenium 0 2


Vitamins


B6, B16 0 2


Folic acid 0 2


Iron 0 7


Magnesim 0 50


Zinc 0 10


Men's Formula
Components Minimum o Maximum


L-carnitine 20 80


Ferulic acid


in Dong Quai 0 20


Vitamins


C and E .Ol 40


Coenzyme


coQlO 0 ~ 10


Selenium 0 3


Zinc 0 15


B vitamins 0 5


Examples of useful formulations in percent by weight are:
Women's Formula
Components
Vitex
(chasteberry 5


L-arginine 50


Green tea 11


Vitamin E 11


Selenium .6


Vitamins


B6, B16 0.38


Folic acid .02


Iron 1


Magnesium 20


Zinc 1


1000





CA 02481603 2004-10-08
WO 03/086080 PCT/US02/10854
Men's Formula
Components % Weight
L-carnitine 60


Ferulic acid in


Dong Quai 6


Vitamins


C and E 30


Coenzyme


coQlO 1


Selenium 0.6


Zinc 2


B vitamins 0.4


1000


In the following, examples 1, 2, 3, provide preferred
ranges of the combinations for men's formula considered in
percent by weight:
Example 1:
Components Minimum a Maximum


L-carnitine 40 70


Ferulic acid in Dong Quai 0.1 10


Vitamins C and E 10 40


Green tea 1 20


Selenium 0.01 1


Zinc 0.1 10


B Vitamins 0.001 1


Example 2:
Components Minimum $ Maximum


L-carnitine 20 80


Ferulic acid in Dong Quai 0 20


Vitamins C and E .O1 40


Green tea 0 30


Selenium 0 3


Zinc 0 15


B vitamins 0 ~ 5





CA 02481603 2004-10-08
WO 03/086080 PCT/US02/10854
6
An example of useful formulations in percent by weight is:
Example 3:
Components ~ Weight
L- carnitine 50.4


Dong quaff (.190 ferulic acid) 8


Vitamins C and E 23


Green tea 17


Selenium 0.1


Zinc 1.3


B Vitamins 0.2


100%
While the invention has been described with references
to specific embodiments, modifications and variations of the
invention may be constructed without departing-from the scope
of the invention, which is defined in the following claims.

Representative Drawing

Sorry, the representative drawing for patent document number 2481603 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date Unavailable
(86) PCT Filing Date 2002-04-08
(87) PCT Publication Date 2003-10-23
(85) National Entry 2004-10-08
Dead Application 2007-04-10

Abandonment History

Abandonment Date Reason Reinstatement Date
2006-04-10 FAILURE TO PAY APPLICATION MAINTENANCE FEE

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $400.00 2004-10-08
Maintenance Fee - Application - New Act 2 2004-04-08 $100.00 2004-10-08
Maintenance Fee - Application - New Act 3 2005-04-08 $100.00 2005-04-04
Registration of a document - section 124 $100.00 2005-09-06
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
THE DAILY WELLNESS COMPANY
Past Owners on Record
TRANT, AILEEN SONTAG
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 2004-10-08 1 57
Claims 2004-10-08 11 311
Description 2004-10-08 6 172
Cover Page 2004-12-22 1 40
Fees 2005-04-04 1 33
PCT 2004-10-08 3 88
Assignment 2004-10-08 4 108
Correspondence 2004-12-14 1 27
Assignment 2005-09-06 2 101
PCT 2004-10-09 3 157